CM
SHAC

Crestline Management’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

Crestline Management’s Portfolio SHAC Stock Details SHAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-51,500
Closed -$504K – 334
2022
Q1 		$504K Hold
51,500
– – 0.06% 174
2021
Q4 		$505K Hold
51,500
– – 0.04% 169
2021
Q3 		$501K Hold
51,500
– – 0.05% 168
2021
Q2 		$499K Buy
+51,500
New +$501K 0.04% 129

Other funds holding SHAC

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Crestline Management's SHAC Position: Q2 2022 in Review

Crestline Management sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q2 2022, closing a stake of 51,500 shares — an estimated $504K sold.

Crestline Management first reported a position in SHAC in Q2 2021 and held it in 4 quarters. The position peaked at $505K in Q4 2021. 69 funds tracked by Wall St. Rank hold SHAC as of Q2 2022.

  • Crestline Management reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q2 2022 after selling out during the quarter.
  • Crestline Management sold 51,500 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q2 2022, an estimated $504K.
  • Crestline Management first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q2 2021 and held it in 4 quarters.
  • Crestline Management's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $505K in Q4 2021.
  • 69 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q2 2022.

Based on Crestline Management's 13F filing for Q2 2022, filed 12 Aug 2022.